Qiagen N.V.

Qiagen N.V. is a global biotechnology company specializing in molecular diagnostics, life sciences research, and applied testing. Founded in 1984 and headquartered in Venlo, Netherlands, Qiagen provides innovative solutions that enable customers to extract, purify, and analyze genetic materials such as DNA, RNA, and proteins from various biological samples. The company's core offerings include sample preparation kits, molecular diagnostic assays, bioinformatics software, and automation systems. Qiagen serves a wide array of sectors including clinical diagnostics, pharmaceutical development, academic research, forensics, and agriculture. Its technologies support advances in personalized medicine, infectious disease detection, cancer genomics, and molecular pathology, catering to over 500,000 customers worldwide. With a strong focus on integrating sample technologies, assay solutions, and data interpretation, Qiagen plays a vital role in enabling scientific discoveries and improving healthcare outcomes globally.